Transient haemoptysis after taking sildenafil

Author:

Karaduman SuheylaORCID,Zarif AzmaeenORCID,Talpeka Alesia,Haseeb Muhammed

Abstract

We report a case of a man in his 70s who developed haemoptysis 3 days after commencing sildenafil. Before postulating a potential connection between sildenafil use and haemoptysis, it is important to rule out potential other causative factors and comorbidities. The patient suffers from multiple medical conditions and takes various medications. On examination, no abnormalities were discovered. There were no recent significant changes in his bloodwork. Cessation of sildenafil coincided with spontaneous symptom resolution. Chest CT was performed, and no abnormalities were reported. Pseudohaemoptysis or malignancy may be the main differential diagnoses of haemoptysis in elderly patients with multiple comorbidities. Concurrent anticoagulation of the patient may predispose to haemoptysis and is likely to be of greater clinical concern.

Publisher

BMJ

Reference16 articles.

1. Pfizer . Viagra (Sildenafil citrate). U.S. Food and Drug Administration; 2014. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf [Accessed 21 Aug 2023].

2. Pfizer . Revatio (Sildenafil). U.S. Food and Drug Administration; 2014. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s011,022473s004,0203109s002lbl.pdf [Accessed 21 Aug 2023].

3. Pfizer . Viagra (Sildenafil citrate). U.S. Food and Drug Administration; 2010. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020895s033lbl.pdf [Accessed 22 Aug 2023].

4. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease;Chida-Nagai;Heart Vessels,2020

5. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations;McHugh;Am J Crit Care,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3